Double-blind trial with chloramphenicol and the combination trimethoprim-sulfamethoxazole in typhoid.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D010919:Placebos; D011743:Pyrimidines; D002701:Chloramphenicol; D014295:Trimethoprim; D013420:Sulfamethoxazole